Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus-Reference-Cited by-同舟云学术

Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus

Published:2019-06 Issue:6 Volume:50 Page:1497-1503
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Ehrlich Matthew E.¹,Liang Li²,Xu Haolin²,Kosinski Andrzej S.³²,Hernandez Adrian F.²,Schwamm Lee H.⁴,Smith Eric E.⁵,Fonarow Gregg C.⁶,Bhatt Deepak L.⁷,Peterson Eric D.⁸²,Xian Ying²

Affiliation:

1. From the Department of Neurology (M.E.E.), Duke University School of Medicine, Durham, NC

2. Duke Clinical Research Institute, Durham, NC (L.L., H.X., A.S.K., A.F.H., E.D.P., Y.X.)

3. Department of Biostatistics and Bioinformatics (A.S.K.), Duke University School of Medicine, Durham, NC

4. Department of Neurology, Institute for Heart, Vascular and Stroke Care, Massachusetts General Hospital (L.H.S.), Harvard Medical School, Boston

5. Department of Neurosciences, Cumming School of Medicine, University of Calgary, Canada (E.E.S.)

6. Division of Cardiology, Ronald Reagan University of California, Los Angeles Medical Center (G.C.F.).

7. Brigham and Women’s Hospital Heart and Vascular Center (D.L.B.), Harvard Medical School, Boston

8. Department of Medicine (E.D.P.), Duke University School of Medicine, Durham, NC

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference36 articles.

1. Tissue Plasminogen Activator for Acute Ischemic Stroke

2. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

3. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

4. The European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products (CPMP) Summary Information on a Referral Opinion Following an Arbitration Pursuant to Article 29 of Directive 2001/83/EC for Actilyse. November 2002.

5. Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: individual-patient-data meta-analysis of randomized trials.;Hacke W;Int J Stroke,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mass spectrometry-based proteomic profiling of extracellular vesicle proteins in diabetic and non-diabetic ischemic stroke patients: a case-control study;Frontiers in Molecular Biosciences;2024-06-14

2. Post-thrombolysis early neurological deterioration occurs with or without hemorrhagic transformation in acute cerebral infarction: risk factors, prediction model and prognosis;Heliyon;2023-05

3. Safety and Efficacy of Intravenous Thrombolysis in the 3- to 4.5-hour Window in Acute Ischemic Stroke Patients Who Have Both Diabetes Mellitus and History of Prior Stroke;Journal of the Korean Neurological Association;2023-05-01

4. Risk factors of hemorrhagic transformation in acute ischaemic stroke: A systematic review and meta-analysis;Frontiers in Neurology;2023-02-20

5. Can metformin use reduce the risk of stroke in diabetic patients? A systematic review and meta-analysis;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-02